Rothschild & Co Redburn’s $127 target on ABT

ABT Abbott Laboratories

$97.5 → $127 (+30%) by Oct 2027

raises · said Oct 2, 2026 · 12-month default horizon

Open: judged on the close on Oct 2, 2027

The article this target came from

Rothschild Redburn upgrades Abbott Labs stock rating on device strength

Investing.com · Oct 2, 2026

raised its price target to $127 from $119

Rothschild & Co Redburn’s track record → Abbott Laboratories →

A fact about what Rothschild & Co Redburn published, as reported by Investing.com, not a recommendation from Dalsna Finance; Rothschild & Co Redburn is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.